The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ebert Charles D since 2005.
The trader's CIK number is 1241752.
At the time of the last reporting, Ebert Charles D was the Development of Allergan Plc. (stock ticker symbol AGN).
Also see all insider trading activities at Allergan Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | ACT | 0 | $0 | 10,877 | $1,726,723 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | WPI | 0 | $0 | 4,981 | $292,837 | 1,000 | $25,640 |
| 2011 | WPI | 0 | $0 | 10,135 | $592,525 | 7,500 | $366,375 |
| 2010 | WPI | 0 | $0 | 32,239 | $1,354,385 | 28,600 | $899,555 |
| 2009 | WPI | 0 | $0 | 19,000 | $726,750 | 19,000 | $515,660 |
| 2005 | WPI | 0 | $0 | 44,400 | $1,464,294 | 0 | $0 |
2. Watson Pharmaceuticals Inc (WPI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-11-06 | ACT | Sale | 10,877 | 158.75 | 1,726,723 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-02-29 | WPI | Sale | 4,981 | 58.79 | 292,837 |
| 2012-02-29 | WPI | Option Ex | 1,000 | 25.64 | 25,640 |
| 2011-06-01 | WPI | Sale | 2,635 | 64.45 | 169,825 |
| 2011-03-03 | WPI | Option Ex | 7,500 | 48.85 | 366,375 |
| 2011-03-03 | WPI | Sale | 7,500 | 56.36 | 422,700 |
| 2010-12-06 | WPI | Sale | 3,639 | 51.00 | 185,589 |
| 2010-03-12 | WPI | Option Ex | 28,600 | 31.45 | 899,555 |
| 2010-03-12 | WPI | Sale | 28,600 | 40.87 | 1,168,796 |
| 2009-12-10 | WPI | Sale | 19,000 | 38.25 | 726,750 |
| 2009-12-10 | WPI | Option Ex | 19,000 | 27.14 | 515,660 |
| 2005-12-01 | WPI | Sale | 17,000 | 33.28 | 565,726 |
| 2005-11-22 | WPI | Sale | 12,400 | 33.17 | 411,369 |
| 2005-11-17 | WPI | Sale | 15,000 | 32.48 | 487,199 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ebert Charles D (Development of Allergan Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.